Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

CXCR3 marks CD4+ memory T lymphocytes that are competent to migrate across a human brain microvascular endothelial cell layer.

Callahan MK, Williams KA, Kivisäkk P, Pearce D, Stins MF, Ransohoff RM.

J Neuroimmunol. 2004 Aug;153(1-2):150-7.

PMID:
15265673
2.

Chemokine receptor CXCR3 expression in inflammatory bowel disease.

Yuan YH, ten Hove T, The FO, Slors JF, van Deventer SJ, te Velde AA.

Inflamm Bowel Dis. 2001 Nov;7(4):281-6.

PMID:
11720316
3.

Phenotypic and functional characterisation of CCR7+ and CCR7- CD4+ memory T cells homing to the joints in juvenile idiopathic arthritis.

Gattorno M, Prigione I, Morandi F, Gregorio A, Chiesa S, Ferlito F, Favre A, Uccelli A, Gambini C, Martini A, Pistoia V.

Arthritis Res Ther. 2005;7(2):R256-67. Epub 2005 Jan 12.

4.

Increased expression of CXCR3 and CCR5 on memory CD4+ T-cells migrating into the cerebrospinal fluid of patients with neuroborreliosis: the role of CXCL10 and CXCL11.

Lepej SZ, Rode OD, Jeren T, Vince A, Remenar A, Barsić B.

J Neuroimmunol. 2005 Jun;163(1-2):128-34. Epub 2005 Apr 19.

PMID:
15885315
5.

Selective recruitment of CXCR3+ and CCR5+ CCR4+ T cells into synovial tissue in patients with rheumatoid arthritis.

Norii M, Yamamura M, Iwahashi M, Ueno A, Yamana J, Makino H.

Acta Med Okayama. 2006 Jun;60(3):149-57.

6.

Altered expression of Th1-type chemokine receptor CXCR3 on CD4+ T cells in myasthenia gravis patients.

Suzuki Y, Onodera H, Tago H, Saito R, Ohuchi M, Shimizu M, Matsumura Y, Kondo T, Yoshie O, Itoyama Y.

J Neuroimmunol. 2006 Mar;172(1-2):166-74. Epub 2006 Jan 19.

PMID:
16427705
7.

CXC chemokine receptor 3 expression increases the disease-inducing potential of CD4+ CD25- T cells in adoptive transfer colitis.

Kristensen NN, Gad M, Thomsen AR, Lu B, Gerard C, Claesson MH.

Inflamm Bowel Dis. 2006 May;12(5):374-81.

PMID:
16670526
8.

Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells.

Muehlinghaus G, Cigliano L, Huehn S, Peddinghaus A, Leyendeckers H, Hauser AE, Hiepe F, Radbruch A, Arce S, Manz RA.

Blood. 2005 May 15;105(10):3965-71. Epub 2005 Feb 1.

9.

Expression and regulation of the chemokine receptor CXCR3 on lymphocytes from normal and inflammatory bowel disease mucosa.

Papadakis KA, Prehn J, Zhu D, Landers C, Gaiennie J, Fleshner PR, Targan SR.

Inflamm Bowel Dis. 2004 Nov;10(6):778-88.

PMID:
15626897
10.
11.

Nickel-responding T cells are CD4+ CLA+ CD45RO+ and express chemokine receptors CXCR3, CCR4 and CCR10.

Moed H, Boorsma DM, Stoof TJ, von Blomberg BM, Bruynzeel DP, Scheper RJ, Gibbs S, Rustemeyer T.

Br J Dermatol. 2004 Jul;151(1):32-41.

PMID:
15270870
12.

Differential roles for CXCR3 in CD4+ and CD8+ T cell trafficking following viral infection of the CNS.

Stiles LN, Hosking MP, Edwards RA, Strieter RM, Lane TE.

Eur J Immunol. 2006 Mar;36(3):613-22.

13.

The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis.

Hensbergen PJ, Wijnands PG, Schreurs MW, Scheper RJ, Willemze R, Tensen CP.

J Immunother. 2005 Jul-Aug;28(4):343-51.

PMID:
16000952
14.

Chemokine transport across human vascular endothelial cells.

Mordelet E, Davies HA, Hillyer P, Romero IA, Male D.

Endothelium. 2007 Jan-Feb;14(1):7-15.

PMID:
17364892
15.

Functional and phenotypic analysis of human memory CD8+ T cells expressing CXCR3.

Kobayashi N, Kondo T, Takata H, Yokota S, Takiguchi M.

J Leukoc Biol. 2006 Aug;80(2):320-9.

16.

Both CXCR3 and CXCL10/IFN-inducible protein 10 are required for resistance to primary infection by dengue virus.

Hsieh MF, Lai SL, Chen JP, Sung JM, Lin YL, Wu-Hsieh BA, Gerard C, Luster A, Liao F.

J Immunol. 2006 Aug 1;177(3):1855-63.

17.

The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.

van Loosdregt J, van Oosterhout MF, Bruggink AH, van Wichen DF, van Kuik J, de Koning E, Baan CC, de Jonge N, Gmelig-Meyling FH, de Weger RA.

Circulation. 2006 Oct 10;114(15):1599-607. Epub 2006 Oct 2.

18.

Chemokine receptor CXCR3 desensitization by IL-16/CD4 signaling is dependent on CCR5 and intact membrane cholesterol.

Rahangdale S, Morgan R, Heijens C, Ryan TC, Yamasaki H, Bentley E, Sullivan E, Center DM, Cruikshank WW.

J Immunol. 2006 Feb 15;176(4):2337-45.

19.

Relationship between expression of chemokine receptors CCR3, CCR5 and CXCR3 on CD4(+) T cells and spontaneous abortion in mice.

Jiang PJ, Lin QD, Bao SM, Zhao AM, Zhang Y, Xiao SJ.

Chin Med J (Engl). 2009 Feb 20;122(4):390-5.

PMID:
19302742
20.

Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis.

Mahad D, Callahan MK, Williams KA, Ubogu EE, Kivisäkk P, Tucky B, Kidd G, Kingsbury GA, Chang A, Fox RJ, Mack M, Sniderman MB, Ravid R, Staugaitis SM, Stins MF, Ransohoff RM.

Brain. 2006 Jan;129(Pt 1):212-23. Epub 2005 Oct 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk